CA2452909A1

CA2452909A1 - Immunostimulatory oligodeoxynucleotides

Immunostimulatory oligodeoxynucleotides Download PDF

Info

Publication number: CA2452909A1
Authority: CA; Canada
Prior art keywords: odn; monothiophosphate; monophosphate; medicine; preparation
Prior art date: 2001-12-07
Legal status : Abandoned

Application number

CA002452909A

Other languages

English (en)

French (fr)

Inventor

Walter Schmidt

Carola Schellack

Alena Egyed

Karen Lingnau

Current Assignee

Valneva Austria GmbH

Original Assignee

Individual

Priority date

2001-12-07

Filing date

2002-12-05

Publication date

2003-06-13

2002-12-05 Application filed by Individual filed Critical Individual

2003-06-13 Publication of CA2452909A1 publication Critical patent/CA2452909A1/en

Status Abandoned legal-status Critical Current

Links

229940046166 oligodeoxynucleotide Drugs 0.000 title claims abstract description 190
230000003308 immunostimulating effect Effects 0.000 title claims abstract description 28
208000030852 Parasitic disease Diseases 0.000 claims abstract description 50
230000001684 chronic effect Effects 0.000 claims abstract description 13
230000001154 acute effect Effects 0.000 claims abstract description 9
210000004027 cell Anatomy 0.000 claims description 170
239000000427 antigen Substances 0.000 claims description 163
108091007433 antigens Proteins 0.000 claims description 163
102000036639 antigens Human genes 0.000 claims description 163
108091034117 Oligonucleotide Proteins 0.000 claims description 149
244000045947 parasite Species 0.000 claims description 98
108090000765 processed proteins & peptides Proteins 0.000 claims description 95
102000004127 Cytokines Human genes 0.000 claims description 82
108090000695 Cytokines Proteins 0.000 claims description 82
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 70
230000028993 immune response Effects 0.000 claims description 70
210000004443 dendritic cell Anatomy 0.000 claims description 64
208000015181 infectious disease Diseases 0.000 claims description 60
241000282414 Homo sapiens Species 0.000 claims description 59
239000003814 drug Substances 0.000 claims description 54
150000007523 nucleic acids Chemical class 0.000 claims description 51
201000010099 disease Diseases 0.000 claims description 47
230000002434 immunopotentiative effect Effects 0.000 claims description 44
108090000623 proteins and genes Proteins 0.000 claims description 41
238000002360 preparation method Methods 0.000 claims description 40
239000000126 substance Substances 0.000 claims description 39
102000039446 nucleic acids Human genes 0.000 claims description 35
108020004707 nucleic acids Proteins 0.000 claims description 35
210000004698 lymphocyte Anatomy 0.000 claims description 33
239000000203 mixture Substances 0.000 claims description 29
238000004519 manufacturing process Methods 0.000 claims description 26
102000004169 proteins and genes Human genes 0.000 claims description 26
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 claims description 23
208000035475 disorder Diseases 0.000 claims description 23
210000000987 immune system Anatomy 0.000 claims description 22
JSRLJPSBLDHEIO-SHYZEUOFSA-N dUMP Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 JSRLJPSBLDHEIO-SHYZEUOFSA-N 0.000 claims description 21
239000002773 nucleotide Substances 0.000 claims description 21
125000003729 nucleotide group Chemical group 0.000 claims description 21
150000004712 monophosphates Chemical class 0.000 claims description 20
210000003719 b-lymphocyte Anatomy 0.000 claims description 19
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 18
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 18
GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 claims description 18
230000001939 inductive effect Effects 0.000 claims description 17
230000000890 antigenic effect Effects 0.000 claims description 15
230000003612 virological effect Effects 0.000 claims description 15
230000003213 activating effect Effects 0.000 claims description 14
101100074998 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nmp-2 gene Proteins 0.000 claims description 12
229920000642 polymer Polymers 0.000 claims description 12
230000004936 stimulating effect Effects 0.000 claims description 11
229960005486 vaccine Drugs 0.000 claims description 11
KHWCHTKSEGGWEX-RRKCRQDMSA-N 2'-deoxyadenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KHWCHTKSEGGWEX-RRKCRQDMSA-N 0.000 claims description 10
108010093488 His-His-His-His-His-His Proteins 0.000 claims description 10
101100074988 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nmp-1 gene Proteins 0.000 claims description 10
230000002710 gonadal effect Effects 0.000 claims description 10
210000000822 natural killer cell Anatomy 0.000 claims description 9
LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 claims description 8
108090000978 Interleukin-4 Proteins 0.000 claims description 8
210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 8
150000003839 salts Chemical class 0.000 claims description 8
208000036142 Viral infection Diseases 0.000 claims description 7
239000002253 acid Substances 0.000 claims description 7
239000003937 drug carrier Substances 0.000 claims description 7
230000001613 neoplastic effect Effects 0.000 claims description 7
238000013268 sustained release Methods 0.000 claims description 7
239000012730 sustained-release form Substances 0.000 claims description 7
206010040047 Sepsis Diseases 0.000 claims description 6
230000000295 complement effect Effects 0.000 claims description 6
238000012423 maintenance Methods 0.000 claims description 6
229940124597 therapeutic agent Drugs 0.000 claims description 6
230000009385 viral infection Effects 0.000 claims description 6
PHNGFPPXDJJADG-RRKCRQDMSA-N 2'-deoxyinosine-5'-monophosphate Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 PHNGFPPXDJJADG-RRKCRQDMSA-N 0.000 claims description 5
108700042778 Antimicrobial Peptides Proteins 0.000 claims description 5
102000044503 Antimicrobial Peptides Human genes 0.000 claims description 5
108010002386 Interleukin-3 Proteins 0.000 claims description 5
210000000612 antigen-presenting cell Anatomy 0.000 claims description 5
230000007812 deficiency Effects 0.000 claims description 5
229940088597 hormone Drugs 0.000 claims description 5
239000005556 hormone Substances 0.000 claims description 5
229910052717 sulfur Inorganic materials 0.000 claims description 5
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 4
102000014509 cathelicidin Human genes 0.000 claims description 4
108060001132 cathelicidin Proteins 0.000 claims description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical group O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims description 4
230000005934 immune activation Effects 0.000 claims description 4
230000001404 mediated effect Effects 0.000 claims description 4
239000000825 pharmaceutical preparation Substances 0.000 claims description 4
229920002851 polycationic polymer Polymers 0.000 claims description 4
230000002195 synergetic effect Effects 0.000 claims description 4
201000000596 systemic lupus erythematosus Diseases 0.000 claims description 4
102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 claims description 3
101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 claims description 3
108010039918 Polylysine Proteins 0.000 claims description 3
239000000872 buffer Substances 0.000 claims description 3
POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 claims description 3
229910052760 oxygen Inorganic materials 0.000 claims description 3
108010011110 polyarginine Proteins 0.000 claims description 3
229920000656 polylysine Polymers 0.000 claims description 3
239000003910 polypeptide antibiotic agent Substances 0.000 claims description 3
FERYXNKLCFJNMG-QJPTWQEYSA-N (2r,3s,5r)-2-(hydroxymethyl)-5-[6-(3-methylbut-3-enylamino)purin-9-yl]oxolan-3-ol Chemical compound C1=NC=2C(NCCC(=C)C)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 FERYXNKLCFJNMG-QJPTWQEYSA-N 0.000 claims description 2
RPFPNGBGDKGFRI-XLPZGREQSA-N 9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methyl-3h-purin-6-one Chemical compound C12=NC(C)=NC(O)=C2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 RPFPNGBGDKGFRI-XLPZGREQSA-N 0.000 claims description 2
108010051696 Growth Hormone Proteins 0.000 claims description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims description 2
108700012920 TNF Proteins 0.000 claims description 2
239000000122 growth hormone Substances 0.000 claims description 2
239000004615 ingredient Substances 0.000 claims description 2
102000018997 Growth Hormone Human genes 0.000 claims 1
102000002265 Human Growth Hormone Human genes 0.000 claims 1
108010000521 Human Growth Hormone Proteins 0.000 claims 1
239000000854 Human Growth Hormone Substances 0.000 claims 1
101500027983 Rattus norvegicus Octadecaneuropeptide Proteins 0.000 claims 1
239000002260 anti-inflammatory agent Substances 0.000 claims 1
230000000845 anti-microbial effect Effects 0.000 claims 1
239000003381 stabilizer Substances 0.000 claims 1
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 abstract description 17
VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 abstract description 17
208000035473 Communicable disease Diseases 0.000 abstract description 10
MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 abstract description 7
MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 abstract description 6
238000000034 method Methods 0.000 description 124
206010028980 Neoplasm Diseases 0.000 description 80
241000700605 Viruses Species 0.000 description 67
241000699670 Mus sp. Species 0.000 description 64
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 63
229940090044 injection Drugs 0.000 description 58
239000007924 injection Substances 0.000 description 58
238000002347 injection Methods 0.000 description 58
241000699666 Mus <mouse, genus> Species 0.000 description 56
229920000724 poly(L-arginine) polymer Polymers 0.000 description 52
108020004414 DNA Proteins 0.000 description 48
108010058846 Ovalbumin Proteins 0.000 description 43
201000011510 cancer Diseases 0.000 description 42
150000001875 compounds Chemical class 0.000 description 42
229940092253 ovalbumin Drugs 0.000 description 41
229940046168 CpG oligodeoxynucleotide Drugs 0.000 description 39
210000001165 lymph node Anatomy 0.000 description 36
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 36
230000014509 gene expression Effects 0.000 description 32
241001465754 Metazoa Species 0.000 description 31
108010062580 Concanavalin A Proteins 0.000 description 30
210000001744 T-lymphocyte Anatomy 0.000 description 29
230000004913 activation Effects 0.000 description 28
238000001994 activation Methods 0.000 description 28
102000004196 processed proteins & peptides Human genes 0.000 description 28
238000011282 treatment Methods 0.000 description 28
238000001727 in vivo Methods 0.000 description 27
239000002158 endotoxin Substances 0.000 description 26
235000018102 proteins Nutrition 0.000 description 23
210000001519 tissue Anatomy 0.000 description 22
239000002609 medium Substances 0.000 description 21
241001430294 unidentified retrovirus Species 0.000 description 21
241000271566 Aves Species 0.000 description 20
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 20
241000223997 Toxoplasma gondii Species 0.000 description 20
241000283690 Bos taurus Species 0.000 description 19
230000006698 induction Effects 0.000 description 19
102100031413 L-dopachrome tautomerase Human genes 0.000 description 18
230000002458 infectious effect Effects 0.000 description 18
230000000638 stimulation Effects 0.000 description 18
-1 2 -isopentenyl-deoxyadenosine-monophosphate Chemical compound 0.000 description 17
230000015572 biosynthetic process Effects 0.000 description 17
210000004369 blood Anatomy 0.000 description 17
239000008280 blood Substances 0.000 description 17
238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 17
238000011510 Elispot assay Methods 0.000 description 16
230000000694 effects Effects 0.000 description 16
LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 15
241000223924 Eimeria Species 0.000 description 15
101710093778 L-dopachrome tautomerase Proteins 0.000 description 15
241000224003 Sarcocystis Species 0.000 description 15
101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 15
235000013350 formula milk Nutrition 0.000 description 15
230000001965 increasing effect Effects 0.000 description 15
201000001441 melanoma Diseases 0.000 description 15
238000003786 synthesis reaction Methods 0.000 description 15
241001494479 Pecora Species 0.000 description 14
208000006673 asthma Diseases 0.000 description 14
230000001580 bacterial effect Effects 0.000 description 14
239000003795 chemical substances by application Substances 0.000 description 14
239000008194 pharmaceutical composition Substances 0.000 description 14
239000013612 plasmid Substances 0.000 description 13
230000002265 prevention Effects 0.000 description 13
230000004044 response Effects 0.000 description 13
241000894006 Bacteria Species 0.000 description 12
241000282472 Canis lupus familiaris Species 0.000 description 12
239000013566 allergen Substances 0.000 description 12
208000026935 allergic disease Diseases 0.000 description 12
229940079593 drug Drugs 0.000 description 12
239000007943 implant Substances 0.000 description 12
238000006116 polymerization reaction Methods 0.000 description 12
229920001184 polypeptide Polymers 0.000 description 12
208000024891 symptom Diseases 0.000 description 12
230000009885 systemic effect Effects 0.000 description 12
241000282326 Felis catus Species 0.000 description 11
102000006354 HLA-DR Antigens Human genes 0.000 description 11
108010058597 HLA-DR Antigens Proteins 0.000 description 11
241000282412 Homo Species 0.000 description 11
108090001005 Interleukin-6 Proteins 0.000 description 11
102000043129 MHC class I family Human genes 0.000 description 11
108091054437 MHC class I family Proteins 0.000 description 11
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 11
238000004128 high performance liquid chromatography Methods 0.000 description 11
244000005700 microbiome Species 0.000 description 11
230000036281 parasite infection Effects 0.000 description 11
108091033319 polynucleotide Proteins 0.000 description 11
102000040430 polynucleotide Human genes 0.000 description 11
239000013598 vector Substances 0.000 description 11
108091003079 Bovine Serum Albumin Proteins 0.000 description 10
241000725585 Chicken anemia virus Species 0.000 description 10
206010020751 Hypersensitivity Diseases 0.000 description 10
108060008682 Tumor Necrosis Factor Proteins 0.000 description 10
201000008680 babesiosis Diseases 0.000 description 10
108010051081 dopachrome isomerase Proteins 0.000 description 10
239000012894 fetal calf serum Substances 0.000 description 10
244000038280 herbivores Species 0.000 description 10
238000004949 mass spectrometry Methods 0.000 description 10
239000011159 matrix material Substances 0.000 description 10
238000012705 nitroxide-mediated radical polymerization Methods 0.000 description 10
239000002157 polynucleotide Substances 0.000 description 10
239000000047 product Substances 0.000 description 10
238000011002 quantification Methods 0.000 description 10
239000007790 solid phase Substances 0.000 description 10
241000223836 Babesia Species 0.000 description 9
238000002965 ELISA Methods 0.000 description 9
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 9
102000013462 Interleukin-12 Human genes 0.000 description 9
108010065805 Interleukin-12 Proteins 0.000 description 9
241000224016 Plasmodium Species 0.000 description 9
241000282898 Sus scrofa Species 0.000 description 9
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 9
241000251539 Vertebrata <Metazoa> Species 0.000 description 9
239000002671 adjuvant Substances 0.000 description 9
230000015556 catabolic process Effects 0.000 description 9
210000003743 erythrocyte Anatomy 0.000 description 9
230000006870 function Effects 0.000 description 9
108020001507 fusion proteins Proteins 0.000 description 9
150000002632 lipids Chemical class 0.000 description 9
244000144972 livestock Species 0.000 description 9
230000003071 parasitic effect Effects 0.000 description 9
210000002966 serum Anatomy 0.000 description 9
239000007787 solid Substances 0.000 description 9
238000013518 transcription Methods 0.000 description 9
230000035897 transcription Effects 0.000 description 9
108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
241000287828 Gallus gallus Species 0.000 description 8
206010025323 Lymphomas Diseases 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 8
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 8
206010039491 Sarcoma Diseases 0.000 description 8
241000243777 Trichinella spiralis Species 0.000 description 8
241000223104 Trypanosoma Species 0.000 description 8
241000223109 Trypanosoma cruzi Species 0.000 description 8
102100040247 Tumor necrosis factor Human genes 0.000 description 8
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 8
230000027455 binding Effects 0.000 description 8
238000009739 binding Methods 0.000 description 8
108010007004 cathelin Proteins 0.000 description 8
235000013330 chicken meat Nutrition 0.000 description 8
239000000306 component Substances 0.000 description 8
238000006731 degradation reaction Methods 0.000 description 8
238000005516 engineering process Methods 0.000 description 8
102000037865 fusion proteins Human genes 0.000 description 8
230000028709 inflammatory response Effects 0.000 description 8
244000000056 intracellular parasite Species 0.000 description 8
230000000813 microbial effect Effects 0.000 description 8
210000001672 ovary Anatomy 0.000 description 8
244000144977 poultry Species 0.000 description 8
235000013594 poultry meat Nutrition 0.000 description 8
238000012360 testing method Methods 0.000 description 8
229940096911 trichinella spiralis Drugs 0.000 description 8
239000003981 vehicle Substances 0.000 description 8
AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 7
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 7
241000251468 Actinopterygii Species 0.000 description 7
102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 7
208000023275 Autoimmune disease Diseases 0.000 description 7
208000035143 Bacterial infection Diseases 0.000 description 7
241000283707 Capra Species 0.000 description 7
241000702421 Dependoparvovirus Species 0.000 description 7
101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 7
241000222722 Leishmania <genus> Species 0.000 description 7
241001529936 Murinae Species 0.000 description 7
208000022362 bacterial infectious disease Diseases 0.000 description 7
238000003745 diagnosis Methods 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
229960002418 ivermectin Drugs 0.000 description 7
239000002502 liposome Substances 0.000 description 7
230000001717 pathogenic effect Effects 0.000 description 7
239000000523 sample Substances 0.000 description 7
241000894007 species Species 0.000 description 7
238000007920 subcutaneous administration Methods 0.000 description 7
238000002255 vaccination Methods 0.000 description 7
210000003462 vein Anatomy 0.000 description 7
JVJGCCBAOOWGEO-RUTPOYCXSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-4-amino-2-[[(2s,3s)-2-[[(2s,3s)-2-[[(2s)-2-azaniumyl-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumy Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 JVJGCCBAOOWGEO-RUTPOYCXSA-N 0.000 description 6
108020000946 Bacterial DNA Proteins 0.000 description 6
101150013553 CD40 gene Proteins 0.000 description 6
241001466804 Carnivora Species 0.000 description 6
241000224432 Entamoeba histolytica Species 0.000 description 6
241000709661 Enterovirus Species 0.000 description 6
241000283086 Equidae Species 0.000 description 6
241000224466 Giardia Species 0.000 description 6
101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 description 6
108010002616 Interleukin-5 Proteins 0.000 description 6
102000000743 Interleukin-5 Human genes 0.000 description 6
241000124008 Mammalia Species 0.000 description 6
102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 description 6
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 6
241001631646 Papillomaviridae Species 0.000 description 6
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 6
230000007815 allergy Effects 0.000 description 6
208000007502 anemia Diseases 0.000 description 6
239000007864 aqueous solution Substances 0.000 description 6
230000005540 biological transmission Effects 0.000 description 6
238000002512 chemotherapy Methods 0.000 description 6
230000001419 dependent effect Effects 0.000 description 6
229940007078 entamoeba histolytica Drugs 0.000 description 6
244000000013 helminth Species 0.000 description 6
230000003834 intracellular effect Effects 0.000 description 6
208000032839 leukemia Diseases 0.000 description 6
239000007788 liquid Substances 0.000 description 6
206010025135 lupus erythematosus Diseases 0.000 description 6
201000004792 malaria Diseases 0.000 description 6
201000006512 mast cell neoplasm Diseases 0.000 description 6
208000006971 mastocytoma Diseases 0.000 description 6
230000004048 modification Effects 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000009325 pulmonary function Effects 0.000 description 6
239000002904 solvent Substances 0.000 description 6
210000001550 testis Anatomy 0.000 description 6
241000701161 unidentified adenovirus Species 0.000 description 6
230000003844 B-cell-activation Effects 0.000 description 5
241000223935 Cryptosporidium Species 0.000 description 5
241000701022 Cytomegalovirus Species 0.000 description 5
241000283073 Equus caballus Species 0.000 description 5
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 5
229930010555 Inosine Natural products 0.000 description 5
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 5
241000567229 Isospora Species 0.000 description 5
241000712079 Measles morbillivirus Species 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
229910019142 PO4 Inorganic materials 0.000 description 5
241000223960 Plasmodium falciparum Species 0.000 description 5
241000223821 Plasmodium malariae Species 0.000 description 5
241001505332 Polyomavirus sp. Species 0.000 description 5
241000700159 Rattus Species 0.000 description 5
241000714474 Rous sarcoma virus Species 0.000 description 5
150000001413 amino acids Chemical class 0.000 description 5
239000002775 capsule Substances 0.000 description 5
230000004663 cell proliferation Effects 0.000 description 5
229920002678 cellulose Polymers 0.000 description 5
230000002209 hydrophobic effect Effects 0.000 description 5
210000002865 immune cell Anatomy 0.000 description 5
238000009169 immunotherapy Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
229960003786 inosine Drugs 0.000 description 5
230000007774 longterm Effects 0.000 description 5
230000009826 neoplastic cell growth Effects 0.000 description 5
230000000590 parasiticidal effect Effects 0.000 description 5
239000002297 parasiticide Substances 0.000 description 5
244000052769 pathogen Species 0.000 description 5
239000010452 phosphate Substances 0.000 description 5
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
230000008569 process Effects 0.000 description 5
YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
238000013519 translation Methods 0.000 description 5
241000712461 unidentified influenza virus Species 0.000 description 5
230000004580 weight loss Effects 0.000 description 5
208000016261 weight loss Diseases 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
108020000948 Antisense Oligonucleotides Proteins 0.000 description 4
241001118702 Border disease virus Species 0.000 description 4
201000009030 Carcinoma Diseases 0.000 description 4
241000710777 Classical swine fever virus Species 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
241000712471 Dhori virus Species 0.000 description 4
241000255925 Diptera Species 0.000 description 4
241000991587 Enterovirus C Species 0.000 description 4
208000001382 Experimental Melanoma Diseases 0.000 description 4
241000282324 Felis Species 0.000 description 4
201000008808 Fibrosarcoma Diseases 0.000 description 4
241000233866 Fungi Species 0.000 description 4
241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 4
241000735426 Hexamita Species 0.000 description 4
241000725303 Human immunodeficiency virus Species 0.000 description 4
102000000646 Interleukin-3 Human genes 0.000 description 4
108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
101710163270 Nuclease Proteins 0.000 description 4
108020005187 Oligonucleotide Probes Proteins 0.000 description 4
241000710778 Pestivirus Species 0.000 description 4
206010037660 Pyrexia Diseases 0.000 description 4
241000702670 Rotavirus Species 0.000 description 4
238000007792 addition Methods 0.000 description 4
229960002669 albendazole Drugs 0.000 description 4
HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 4
229960004784 allergens Drugs 0.000 description 4
125000000539 amino acid group Chemical group 0.000 description 4
230000003172 anti-dna Effects 0.000 description 4
239000000074 antisense oligonucleotide Substances 0.000 description 4
238000012230 antisense oligonucleotides Methods 0.000 description 4
210000001185 bone marrow Anatomy 0.000 description 4
125000002091 cationic group Chemical group 0.000 description 4
239000001913 cellulose Substances 0.000 description 4
235000010980 cellulose Nutrition 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
239000002299 complementary DNA Substances 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
230000034994 death Effects 0.000 description 4
231100000517 death Toxicity 0.000 description 4
241001493065 dsRNA viruses Species 0.000 description 4
229960005473 fenbendazole Drugs 0.000 description 4
HDDSHPAODJUKPD-UHFFFAOYSA-N fenbendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 HDDSHPAODJUKPD-UHFFFAOYSA-N 0.000 description 4
238000005188 flotation Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
206010022000 influenza Diseases 0.000 description 4
230000003993 interaction Effects 0.000 description 4
238000001990 intravenous administration Methods 0.000 description 4
230000000670 limiting effect Effects 0.000 description 4
210000004072 lung Anatomy 0.000 description 4
208000020816 lung neoplasm Diseases 0.000 description 4
239000002751 oligonucleotide probe Substances 0.000 description 4
210000005259 peripheral blood Anatomy 0.000 description 4
239000011886 peripheral blood Substances 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
229960005141 piperazine Drugs 0.000 description 4
229920000729 poly(L-lysine) polymer Polymers 0.000 description 4
229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 4
238000011321 prophylaxis Methods 0.000 description 4
229960005134 pyrantel Drugs 0.000 description 4
239000000243 solution Substances 0.000 description 4
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
229920001059 synthetic polymer Polymers 0.000 description 4
239000003826 tablet Substances 0.000 description 4
229960004546 thiabendazole Drugs 0.000 description 4
WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 4
239000004308 thiabendazole Substances 0.000 description 4
235000010296 thiabendazole Nutrition 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
230000001960 triggered effect Effects 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
102100025230 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial Human genes 0.000 description 3
208000030507 AIDS Diseases 0.000 description 3
108010087522 Aeromonas hydrophilia lipase-acyltransferase Proteins 0.000 description 3
241000238421 Arthropoda Species 0.000 description 3
206010003645 Atopy Diseases 0.000 description 3
241001235572 Balantioides coli Species 0.000 description 3
208000003174 Brain Neoplasms Diseases 0.000 description 3
206010006187 Breast cancer Diseases 0.000 description 3
208000026310 Breast neoplasm Diseases 0.000 description 3
102100035793 CD83 antigen Human genes 0.000 description 3
241000282693 Cercopithecidae Species 0.000 description 3
241000080444 Cytauxzoon sp. Species 0.000 description 3
241000450599 DNA viruses Species 0.000 description 3
206010012735 Diarrhoea Diseases 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
108060002716 Exonuclease Proteins 0.000 description 3
206010017533 Fungal infection Diseases 0.000 description 3
101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 3
241000224470 Giardia sp. Species 0.000 description 3
241000282818 Giraffidae Species 0.000 description 3
101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 3
208000034767 Hypoproteinaemia Diseases 0.000 description 3
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
208000029462 Immunodeficiency disease Diseases 0.000 description 3
206010062016 Immunosuppression Diseases 0.000 description 3
206010061218 Inflammation Diseases 0.000 description 3
HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 3
208000031888 Mycoses Diseases 0.000 description 3
206010030113 Oedema Diseases 0.000 description 3
241000712464 Orthomyxoviridae Species 0.000 description 3
241000150218 Orthonairovirus Species 0.000 description 3
241000282320 Panthera leo Species 0.000 description 3
241000711504 Paramyxoviridae Species 0.000 description 3
208000002606 Paramyxoviridae Infections Diseases 0.000 description 3
241000713137 Phlebovirus Species 0.000 description 3
241000223810 Plasmodium vivax Species 0.000 description 3
241000288906 Primates Species 0.000 description 3
241000711798 Rabies lyssavirus Species 0.000 description 3
241000712909 Reticuloendotheliosis virus Species 0.000 description 3
201000000582 Retinoblastoma Diseases 0.000 description 3
241000283984 Rodentia Species 0.000 description 3
241000710799 Rubella virus Species 0.000 description 3
208000000453 Skin Neoplasms Diseases 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
229920002125 Sokalan® Polymers 0.000 description 3
241000194017 Streptococcus Species 0.000 description 3
230000024932 T cell mediated immunity Effects 0.000 description 3
241000223777 Theileria Species 0.000 description 3
241000710924 Togaviridae Species 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
241000223996 Toxoplasma Species 0.000 description 3
241000557621 Trichomonas gallinae Species 0.000 description 3
241001442399 Trypanosoma brucei gambiense Species 0.000 description 3
241000700618 Vaccinia virus Species 0.000 description 3
239000012190 activator Substances 0.000 description 3
230000001464 adherent effect Effects 0.000 description 3
230000000172 allergic effect Effects 0.000 description 3
238000010171 animal model Methods 0.000 description 3
208000010668 atopic eczema Diseases 0.000 description 3
208000007456 balantidiasis Diseases 0.000 description 3
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 3
239000011230 binding agent Substances 0.000 description 3
208000035269 cancer or benign tumor Diseases 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000001246 colloidal dispersion Methods 0.000 description 3
239000003433 contraceptive agent Substances 0.000 description 3
230000002254 contraceptive effect Effects 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
230000002950 deficient Effects 0.000 description 3
230000003111 delayed effect Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 3
229950001327 dichlorvos Drugs 0.000 description 3
230000004069 differentiation Effects 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
IBXPYPUJPLLOIN-UHFFFAOYSA-N dimetridazole Chemical compound CC1=NC=C(N(=O)=O)N1C IBXPYPUJPLLOIN-UHFFFAOYSA-N 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
102000013165 exonuclease Human genes 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
206010016629 fibroma Diseases 0.000 description 3
239000012530 fluid Substances 0.000 description 3
239000012634 fragment Substances 0.000 description 3
230000002538 fungal effect Effects 0.000 description 3
230000004927 fusion Effects 0.000 description 3
210000001035 gastrointestinal tract Anatomy 0.000 description 3
150000004676 glycans Chemical class 0.000 description 3
239000008187 granular material Substances 0.000 description 3
230000012010 growth Effects 0.000 description 3
239000000017 hydrogel Substances 0.000 description 3
230000016784 immunoglobulin production Effects 0.000 description 3
230000001506 immunosuppresive effect Effects 0.000 description 3
230000001976 improved effect Effects 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
230000004054 inflammatory process Effects 0.000 description 3
230000003902 lesion Effects 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
229960001614 levamisole Drugs 0.000 description 3
229920006008 lipopolysaccharide Polymers 0.000 description 3
208000025036 lymphosarcoma Diseases 0.000 description 3
230000002101 lytic effect Effects 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
230000035772 mutation Effects 0.000 description 3
208000003154 papilloma Diseases 0.000 description 3
239000002245 particle Substances 0.000 description 3
230000037361 pathway Effects 0.000 description 3
239000013600 plasmid vector Substances 0.000 description 3
229940118768 plasmodium malariae Drugs 0.000 description 3
229920001282 polysaccharide Polymers 0.000 description 3
239000005017 polysaccharide Substances 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
206010041823 squamous cell carcinoma Diseases 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
239000000725 suspension Substances 0.000 description 3
238000010361 transduction Methods 0.000 description 3
230000026683 transduction Effects 0.000 description 3
238000012546 transfer Methods 0.000 description 3
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 3
229940045145 uridine Drugs 0.000 description 3
239000002699 waste material Substances 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
MIHADVKEHAFNPG-UHFFFAOYSA-N 2-Amino-5-nitrothiazole Chemical compound NC1=NC=C([N+]([O-])=O)S1 MIHADVKEHAFNPG-UHFFFAOYSA-N 0.000 description 2
VUFNLQXQSDUXKB-DOFZRALJSA-N 2-[4-[4-[bis(2-chloroethyl)amino]phenyl]butanoyloxy]ethyl (5z,8z,11z,14z)-icosa-5,8,11,14-tetraenoate Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OCCOC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 VUFNLQXQSDUXKB-DOFZRALJSA-N 0.000 description 2
FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 2
XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
241000238876 Acari Species 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
208000000230 African Trypanosomiasis Diseases 0.000 description 2
241000701386 African swine fever virus Species 0.000 description 2
241000219496 Alnus Species 0.000 description 2
206010001935 American trypanosomiasis Diseases 0.000 description 2
241000272517 Anseriformes Species 0.000 description 2
102000006306 Antigen Receptors Human genes 0.000 description 2
108010083359 Antigen Receptors Proteins 0.000 description 2
241000712892 Arenaviridae Species 0.000 description 2
235000003826 Artemisia Nutrition 0.000 description 2
235000003261 Artemisia vulgaris Nutrition 0.000 description 2
244000075850 Avena orientalis Species 0.000 description 2
241000714230 Avian leukemia virus Species 0.000 description 2
241000713838 Avian myeloblastosis virus Species 0.000 description 2
241001455947 Babesia divergens Species 0.000 description 2
241000282817 Bovidae Species 0.000 description 2
241001227615 Bovine foamy virus Species 0.000 description 2
241000714266 Bovine leukemia virus Species 0.000 description 2
241000711895 Bovine orthopneumovirus Species 0.000 description 2
241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
108010029697 CD40 Ligand Proteins 0.000 description 2
102100032937 CD40 ligand Human genes 0.000 description 2
241000282832 Camelidae Species 0.000 description 2
241000700199 Cavia porcellus Species 0.000 description 2
208000024699 Chagas disease Diseases 0.000 description 2
244000281762 Chenopodium ambrosioides Species 0.000 description 2
235000000509 Chenopodium ambrosioides Nutrition 0.000 description 2
235000005490 Chenopodium botrys Nutrition 0.000 description 2
229920001661 Chitosan Polymers 0.000 description 2
206010008583 Chloroma Diseases 0.000 description 2
208000017667 Chronic Disease Diseases 0.000 description 2
208000003495 Coccidiosis Diseases 0.000 description 2
206010009944 Colon cancer Diseases 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 2
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
240000005109 Cryptomeria japonica Species 0.000 description 2
241000295636 Cryptosporidium sp. Species 0.000 description 2
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
241000725619 Dengue virus Species 0.000 description 2
201000004624 Dermatitis Diseases 0.000 description 2
208000000655 Distemper Diseases 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
108010042407 Endonucleases Proteins 0.000 description 2
206010066919 Epidemic polyarthritis Diseases 0.000 description 2
241000713730 Equine infectious anemia virus Species 0.000 description 2
HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 2
241000192125 Firmicutes Species 0.000 description 2
241000710198 Foot-and-mouth disease virus Species 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
241000699694 Gerbillinae Species 0.000 description 2
241000224467 Giardia intestinalis Species 0.000 description 2
241000224468 Giardia muris Species 0.000 description 2
241000713813 Gibbon ape leukemia virus Species 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
241000856850 Goose coronavirus Species 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
241001301839 Haemoproteus Species 0.000 description 2
208000032843 Hemorrhage Diseases 0.000 description 2
208000032456 Hemorrhagic Shock Diseases 0.000 description 2
241000700721 Hepatitis B virus Species 0.000 description 2
208000005176 Hepatitis C Diseases 0.000 description 2
241000709721 Hepatovirus A Species 0.000 description 2
208000009889 Herpes Simplex Diseases 0.000 description 2
241000700586 Herpesviridae Species 0.000 description 2
241000948219 Histomonas Species 0.000 description 2
241000713673 Human foamy virus Species 0.000 description 2
241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
241000726041 Human respirovirus 1 Species 0.000 description 2
241000714192 Human spumaretrovirus Species 0.000 description 2
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 2
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
241000711450 Infectious bronchitis virus Species 0.000 description 2
241000702626 Infectious bursal disease virus Species 0.000 description 2
241000712431 Influenza A virus Species 0.000 description 2
108010074328 Interferon-gamma Proteins 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
108090000174 Interleukin-10 Proteins 0.000 description 2
108090000172 Interleukin-15 Proteins 0.000 description 2
241000701377 Iridoviridae Species 0.000 description 2
206010023076 Isosporiasis Diseases 0.000 description 2
241000710842 Japanese encephalitis virus Species 0.000 description 2
241000721662 Juniperus Species 0.000 description 2
241000710912 Kunjin virus Species 0.000 description 2
241000222740 Leishmania braziliensis Species 0.000 description 2
241000222727 Leishmania donovani Species 0.000 description 2
241000222736 Leishmania tropica Species 0.000 description 2
241000713666 Lentivirus Species 0.000 description 2
241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
241000713821 Mason-Pfizer monkey virus Species 0.000 description 2
102000003792 Metallothionein Human genes 0.000 description 2
108090000157 Metallothionein Proteins 0.000 description 2
241000713862 Moloney murine sarcoma virus Species 0.000 description 2
241000712045 Morbillivirus Species 0.000 description 2
208000005647 Mumps Diseases 0.000 description 2
241000714177 Murine leukemia virus Species 0.000 description 2
241000711408 Murine respirovirus Species 0.000 description 2
241000710908 Murray Valley encephalitis virus Species 0.000 description 2
241000282339 Mustela Species 0.000 description 2
241001494191 Myxobolus Species 0.000 description 2
RAOCRURYZCVHMG-UHFFFAOYSA-N N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)NC2=C1 RAOCRURYZCVHMG-UHFFFAOYSA-N 0.000 description 2
206010029260 Neuroblastoma Diseases 0.000 description 2
FQSUTLQHSDLLAN-UHFFFAOYSA-N Nithiazide Chemical compound CCNC(=O)NC1=NC=C([N+]([O-])=O)S1 FQSUTLQHSDLLAN-UHFFFAOYSA-N 0.000 description 2
241001126829 Nosema Species 0.000 description 2
241000710944 O'nyong-nyong virus Species 0.000 description 2
241000795633 Olea <sea slug> Species 0.000 description 2
241000725177 Omsk hemorrhagic fever virus Species 0.000 description 2
206010033128 Ovarian cancer Diseases 0.000 description 2
206010061535 Ovarian neoplasm Diseases 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
241001330453 Paspalum Species 0.000 description 2
241000150350 Peribunyaviridae Species 0.000 description 2
241000286209 Phasianidae Species 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
241000709664 Picornaviridae Species 0.000 description 2
241000223801 Plasmodium knowlesi Species 0.000 description 2
206010035501 Plasmodium malariae infection Diseases 0.000 description 2
241001505293 Plasmodium ovale Species 0.000 description 2
241000223830 Plasmodium yoelii Species 0.000 description 2
241000711902 Pneumovirus Species 0.000 description 2
229920001305 Poly(isodecyl(meth)acrylate) Polymers 0.000 description 2
229920002319 Poly(methyl acrylate) Polymers 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
241000710884 Powassan virus Species 0.000 description 2
241000700625 Poxviridae Species 0.000 description 2
206010060862 Prostate cancer Diseases 0.000 description 2
241000125945 Protoparvovirus Species 0.000 description 2
208000010362 Protozoan Infections Diseases 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
241000702247 Reoviridae Species 0.000 description 2
241000725643 Respiratory syncytial virus Species 0.000 description 2
241000711931 Rhabdoviridae Species 0.000 description 2
241000713124 Rift Valley fever virus Species 0.000 description 2
241000711897 Rinderpest morbillivirus Species 0.000 description 2
241000710942 Ross River virus Species 0.000 description 2
241000710801 Rubivirus Species 0.000 description 2
241000607142 Salmonella Species 0.000 description 2
241001135555 Sandfly fever Sicilian virus Species 0.000 description 2
241000242678 Schistosoma Species 0.000 description 2
206010049771 Shock haemorrhagic Diseases 0.000 description 2
241001529934 Simian T-lymphotropic virus 3 Species 0.000 description 2
241000713656 Simian foamy virus Species 0.000 description 2
241000710960 Sindbis virus Species 0.000 description 2
208000001203 Smallpox Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
244000062793 Sorghum vulgare Species 0.000 description 2
241000713896 Spleen necrosis virus Species 0.000 description 2
241000710888 St. Louis encephalitis virus Species 0.000 description 2
229930182558 Sterol Natural products 0.000 description 2
208000005718 Stomach Neoplasms Diseases 0.000 description 2
241000282887 Suidae Species 0.000 description 2
241000725681 Swine influenza virus Species 0.000 description 2
208000000389 T-cell leukemia Diseases 0.000 description 2
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 2
208000024313 Testicular Neoplasms Diseases 0.000 description 2
241000218636 Thuja Species 0.000 description 2
241000242541 Trematoda Species 0.000 description 2
241000243774 Trichinella Species 0.000 description 2
206010044608 Trichiniasis Diseases 0.000 description 2
208000005448 Trichomonas Infections Diseases 0.000 description 2
206010044620 Trichomoniasis Diseases 0.000 description 2
241001442397 Trypanosoma brucei rhodesiense Species 0.000 description 2
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 2
208000024780 Urticaria Diseases 0.000 description 2
241000713152 Uukuniemi virus Species 0.000 description 2
241000710959 Venezuelan equine encephalitis virus Species 0.000 description 2
241000711975 Vesicular stomatitis virus Species 0.000 description 2
241000711970 Vesiculovirus Species 0.000 description 2
208000021017 Weight Gain Diseases 0.000 description 2
206010047897 Weight gain poor Diseases 0.000 description 2
241000710886 West Nile virus Species 0.000 description 2
241000710951 Western equine encephalitis virus Species 0.000 description 2
208000008383 Wilms tumor Diseases 0.000 description 2
241000714205 Woolly monkey sarcoma virus Species 0.000 description 2
241000710772 Yellow fever virus Species 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
239000000654 additive Substances 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
230000002411 adverse Effects 0.000 description 2
239000000443 aerosol Substances 0.000 description 2
229940072056 alginate Drugs 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
208000022531 anorexia Diseases 0.000 description 2
230000002141 anti-parasite Effects 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
244000030166 artemisia Species 0.000 description 2
235000009052 artemisia Nutrition 0.000 description 2
238000003556 assay Methods 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000005784 autoimmunity Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000000227 bioadhesive Substances 0.000 description 2
229920002988 biodegradable polymer Polymers 0.000 description 2
239000004621 biodegradable polymer Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
238000002619 cancer immunotherapy Methods 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000022131 cell cycle Effects 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
108091092356 cellular DNA Proteins 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
208000024207 chronic leukemia Diseases 0.000 description 2
238000000576 coating method Methods 0.000 description 2
210000001072 colon Anatomy 0.000 description 2
208000029742 colonic neoplasm Diseases 0.000 description 2
229940000425 combination drug Drugs 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
230000000120 cytopathologic effect Effects 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
206010061428 decreased appetite Diseases 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
229960000946 dimetridazole Drugs 0.000 description 2
208000009190 disseminated intravascular coagulation Diseases 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003651 drinking water Substances 0.000 description 2
235000020188 drinking water Nutrition 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
239000000284 extract Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
229960005282 febantel Drugs 0.000 description 2
230000002550 fecal effect Effects 0.000 description 2
244000144992 flock Species 0.000 description 2
108700014844 flt3 ligand Proteins 0.000 description 2
238000005755 formation reaction Methods 0.000 description 2
238000009472 formulation Methods 0.000 description 2
230000005714 functional activity Effects 0.000 description 2
108010074605 gamma-Globulins Proteins 0.000 description 2
206010017758 gastric cancer Diseases 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
229940029575 guanosine Drugs 0.000 description 2
230000001894 hemadsorption Effects 0.000 description 2
208000029080 human African trypanosomiasis Diseases 0.000 description 2
230000008348 humoral response Effects 0.000 description 2
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
230000007124 immune defense Effects 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000001031 immunopharmacological effect Effects 0.000 description 2
238000002513 implantation Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
229940102223 injectable solution Drugs 0.000 description 2
230000015788 innate immune response Effects 0.000 description 2
230000003434 inspiratory effect Effects 0.000 description 2
230000010354 integration Effects 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
201000007270 liver cancer Diseases 0.000 description 2
208000014018 liver neoplasm Diseases 0.000 description 2
230000004199 lung function Effects 0.000 description 2
201000003866 lung sarcoma Diseases 0.000 description 2
208000037841 lung tumor Diseases 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
239000000463 material Substances 0.000 description 2
230000035800 maturation Effects 0.000 description 2
229960003439 mebendazole Drugs 0.000 description 2
OPXLLQIJSORQAM-UHFFFAOYSA-N mebendazole Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(=O)C1=CC=CC=C1 OPXLLQIJSORQAM-UHFFFAOYSA-N 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
230000011987 methylation Effects 0.000 description 2
238000007069 methylation reaction Methods 0.000 description 2
229960001952 metrifonate Drugs 0.000 description 2
VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
229960000282 metronidazole Drugs 0.000 description 2
239000000693 micelle Substances 0.000 description 2
239000003094 microcapsule Substances 0.000 description 2
239000011859 microparticle Substances 0.000 description 2
239000004005 microsphere Substances 0.000 description 2
230000002297 mitogenic effect Effects 0.000 description 2
201000006417 multiple sclerosis Diseases 0.000 description 2
208000010805 mumps infectious disease Diseases 0.000 description 2
201000005987 myeloid sarcoma Diseases 0.000 description 2
239000013642 negative control Substances 0.000 description 2
201000008026 nephroblastoma Diseases 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
239000000346 nonvolatile oil Substances 0.000 description 2
239000002777 nucleoside Substances 0.000 description 2
FSAJWMJJORKPKS-UHFFFAOYSA-N octadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C=C FSAJWMJJORKPKS-UHFFFAOYSA-N 0.000 description 2
201000008968 osteosarcoma Diseases 0.000 description 2
BEZZFPOZAYTVHN-UHFFFAOYSA-N oxfendazole Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1S(=O)C1=CC=CC=C1 BEZZFPOZAYTVHN-UHFFFAOYSA-N 0.000 description 2
229960004454 oxfendazole Drugs 0.000 description 2
229960002762 oxibendazole Drugs 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
150000003904 phospholipids Chemical group 0.000 description 2
229920001308 poly(aminoacid) Polymers 0.000 description 2
229920000212 poly(isobutyl acrylate) Polymers 0.000 description 2
229920000205 poly(isobutyl methacrylate) Polymers 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
229920000197 polyisopropyl acrylate Polymers 0.000 description 2
229920000182 polyphenyl methacrylate Polymers 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
229920002635 polyurethane Polymers 0.000 description 2
239000004814 polyurethane Substances 0.000 description 2
229920002451 polyvinyl alcohol Polymers 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
229960002957 praziquantel Drugs 0.000 description 2
230000000770 proinflammatory effect Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
230000002685 pulmonary effect Effects 0.000 description 2
229960000996 pyrantel pamoate Drugs 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
210000000664 rectum Anatomy 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
210000002345 respiratory system Anatomy 0.000 description 2
208000023504 respiratory system disease Diseases 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
201000004409 schistosomiasis Diseases 0.000 description 2
238000007790 scraping Methods 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
201000000849 skin cancer Diseases 0.000 description 2
201000002612 sleeping sickness Diseases 0.000 description 2
YQDGWZZYGYKDLR-UZVLBLASSA-K sodium stibogluconate Chemical compound O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].O1[C@H]([C@H](O)CO)[C@H](O2)[C@H](C([O-])=O)O[Sb]21([O-])O[Sb]1(O)(O[C@H]2C([O-])=O)O[C@H]([C@H](O)CO)[C@@H]2O1 YQDGWZZYGYKDLR-UZVLBLASSA-K 0.000 description 2
229960001567 sodium stibogluconate Drugs 0.000 description 2
235000003702 sterols Nutrition 0.000 description 2
150000003432 sterols Chemical class 0.000 description 2
201000011549 stomach cancer Diseases 0.000 description 2
239000000829 suppository Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
201000003120 testicular cancer Diseases 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
238000001890 transfection Methods 0.000 description 2
208000003982 trichinellosis Diseases 0.000 description 2
201000007588 trichinosis Diseases 0.000 description 2
NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 2
102000003390 tumor necrosis factor Human genes 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
241000519615 unidentified simian type D retrovirus Species 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
239000012646 vaccine adjuvant Substances 0.000 description 2
229940124931 vaccine adjuvant Drugs 0.000 description 2
230000002477 vacuolizing effect Effects 0.000 description 2
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
239000000277 virosome Substances 0.000 description 2
230000004584 weight gain Effects 0.000 description 2
235000019786 weight gain Nutrition 0.000 description 2
229940051021 yellow-fever virus Drugs 0.000 description 2
XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 description 1
JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 1
VWRCYAZJKNPEQR-NIEARKAZSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCCN=C1\C=C\C1=CC=CS1 VWRCYAZJKNPEQR-NIEARKAZSA-N 0.000 description 1
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
AKYHKWQPZHDOBW-UHFFFAOYSA-N (5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol Chemical compound OS(O)(=O)=O.C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-UHFFFAOYSA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
QOVTVIYTBRHADL-UHFFFAOYSA-N 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide Chemical compound NC1=CC(C(Cl)=C(Cl)Cl)=C(S(N)(=O)=O)C=C1S(N)(=O)=O QOVTVIYTBRHADL-UHFFFAOYSA-N 0.000 description 1
NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 description 1
AEUAEICGCMSYCQ-UHFFFAOYSA-N 4-n-(7-chloroquinolin-1-ium-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;dihydrogen phosphate Chemical compound OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 AEUAEICGCMSYCQ-UHFFFAOYSA-N 0.000 description 1
101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
GJOHLWZHWQUKAU-UHFFFAOYSA-N 5-azaniumylpentan-2-yl-(6-methoxyquinolin-8-yl)azanium;dihydrogen phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 GJOHLWZHWQUKAU-UHFFFAOYSA-N 0.000 description 1
FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
206010060921 Abdominal abscess Diseases 0.000 description 1
206010000084 Abdominal pain lower Diseases 0.000 description 1
241000224422 Acanthamoeba Species 0.000 description 1
208000010444 Acidosis Diseases 0.000 description 1
241001455214 Acinonyx jubatus Species 0.000 description 1
241000186046 Actinomyces Species 0.000 description 1
102100036664 Adenosine deaminase Human genes 0.000 description 1
241000701242 Adenoviridae Species 0.000 description 1
241000282813 Aepyceros melampus Species 0.000 description 1
241000120516 African horse sickness virus Species 0.000 description 1
208000008190 Agammaglobulinemia Diseases 0.000 description 1
241000209136 Agropyron Species 0.000 description 1
241000743339 Agrostis Species 0.000 description 1
240000005611 Agrostis gigantea Species 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
241001135972 Aleutian mink disease virus Species 0.000 description 1
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
206010027654 Allergic conditions Diseases 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
241000223600 Alternaria Species 0.000 description 1
241000223602 Alternaria alternata Species 0.000 description 1
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
241000272525 Anas platyrhynchos Species 0.000 description 1
241001465677 Ancylostomatoidea Species 0.000 description 1
201000003076 Angiosarcoma Diseases 0.000 description 1
235000002198 Annona diversifolia Nutrition 0.000 description 1
241000272814 Anser sp. Species 0.000 description 1
108700031308 Antennapedia Homeodomain Proteins 0.000 description 1
241000743857 Anthoxanthum Species 0.000 description 1
240000004178 Anthoxanthum odoratum Species 0.000 description 1
235000014251 Anthoxanthum odoratum Nutrition 0.000 description 1
102000014133 Antimicrobial Cationic Peptides Human genes 0.000 description 1
108010050820 Antimicrobial Cationic Peptides Proteins 0.000 description 1
241000269350 Anura Species 0.000 description 1
241000508787 Arrhenatherum Species 0.000 description 1
241000508786 Arrhenatherum elatius Species 0.000 description 1
241000701061 Ateline gammaherpesvirus 2 Species 0.000 description 1
241000984758 Atoxoplasma Species 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
235000005781 Avena Nutrition 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
241000701802 Aviadenovirus Species 0.000 description 1
241000711404 Avian avulavirus 1 Species 0.000 description 1
241001213911 Avian retroviruses Species 0.000 description 1
241000606767 Avibacterium paragallinarum Species 0.000 description 1
241000700663 Avipoxvirus Species 0.000 description 1
102100035634 B-cell linker protein Human genes 0.000 description 1
208000003950 B-cell lymphoma Diseases 0.000 description 1
241000223840 Babesia bigemina Species 0.000 description 1
241000223838 Babesia bovis Species 0.000 description 1
241000223848 Babesia microti Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
208000008035 Back Pain Diseases 0.000 description 1
201000001178 Bacterial Pneumonia Diseases 0.000 description 1
241001148536 Bacteroides sp. Species 0.000 description 1
241001235574 Balantidium Species 0.000 description 1
208000005440 Basal Cell Neoplasms Diseases 0.000 description 1
206010004146 Basal cell carcinoma Diseases 0.000 description 1
CULUWZNBISUWAS-UHFFFAOYSA-N Benznidazole Chemical compound [O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1 CULUWZNBISUWAS-UHFFFAOYSA-N 0.000 description 1
241000359271 Besnoitia Species 0.000 description 1
241000219429 Betula Species 0.000 description 1
235000003932 Betula Nutrition 0.000 description 1
241000219430 Betula pendula Species 0.000 description 1
235000009109 Betula pendula Nutrition 0.000 description 1
241000219495 Betulaceae Species 0.000 description 1
241000702628 Birnaviridae Species 0.000 description 1
241000228405 Blastomyces dermatitidis Species 0.000 description 1
241000238658 Blattella Species 0.000 description 1
241000238657 Blattella germanica Species 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
241000120506 Bluetongue virus Species 0.000 description 1
241001416152 Bos frontalis Species 0.000 description 1
241000701083 Bovine alphaherpesvirus 1 Species 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
241000621124 Bovine papular stomatitis virus Species 0.000 description 1
241000701922 Bovine parvovirus Species 0.000 description 1
241001506128 Bovine rotavirus strain NCDV/G6 Species 0.000 description 1
241000209200 Bromus Species 0.000 description 1
241000743756 Bromus inermis Species 0.000 description 1
206010058354 Bronchioloalveolar carcinoma Diseases 0.000 description 1
206010006482 Bronchospasm Diseases 0.000 description 1
208000011691 Burkitt lymphomas Diseases 0.000 description 1
208000027312 Bursal disease Diseases 0.000 description 1
208000008889 California Encephalitis Diseases 0.000 description 1
241000589994 Campylobacter sp. Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
241000282421 Canidae Species 0.000 description 1
241000701931 Canine parvovirus Species 0.000 description 1
241000282465 Canis Species 0.000 description 1
241000700664 Capripoxvirus Species 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
208000009458 Carcinoma in Situ Diseases 0.000 description 1
241000710190 Cardiovirus Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
229920002284 Cellulose triacetate Polymers 0.000 description 1
206010007953 Central nervous system lymphoma Diseases 0.000 description 1
206010063094 Cerebral malaria Diseases 0.000 description 1
241000282994 Cervidae Species 0.000 description 1
241000283153 Cetacea Species 0.000 description 1
241000723437 Chamaecyparis Species 0.000 description 1
241001502567 Chikungunya virus Species 0.000 description 1
241001629481 Chilodonella Species 0.000 description 1
229920002101 Chitin Polymers 0.000 description 1
241000606153 Chlamydia trachomatis Species 0.000 description 1
208000006332 Choriocarcinoma Diseases 0.000 description 1
244000249211 Cissus discolor Species 0.000 description 1
235000000469 Cissus discolor Nutrition 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
241000193449 Clostridium tetani Species 0.000 description 1
241000224483 Coccidia Species 0.000 description 1
241000223205 Coccidioides immitis Species 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
208000009802 Colorado tick fever Diseases 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
241000272201 Columbiformes Species 0.000 description 1
206010010071 Coma Diseases 0.000 description 1
206010010904 Convulsion Diseases 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
241000186227 Corynebacterium diphtheriae Species 0.000 description 1
241000186225 Corynebacterium pseudotuberculosis Species 0.000 description 1
241000186249 Corynebacterium sp. Species 0.000 description 1
241001125840 Coryphaenidae Species 0.000 description 1
241000709687 Coxsackievirus Species 0.000 description 1
208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
241000895520 Cryptobia Species 0.000 description 1
201000007336 Cryptococcosis Diseases 0.000 description 1
241000221204 Cryptococcus neoformans Species 0.000 description 1
241001126716 Cryptosporidium baileyi Species 0.000 description 1
241000333156 Cryptosporidium meleagridis Species 0.000 description 1
240000004244 Cucurbita moschata Species 0.000 description 1
235000009854 Cucurbita moschata Nutrition 0.000 description 1
235000009852 Cucurbita pepo Nutrition 0.000 description 1
241000723198 Cupressus Species 0.000 description 1
244000301850 Cupressus sempervirens Species 0.000 description 1
201000005171 Cystadenoma Diseases 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
241000209630 Cystoisospora suis Species 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
230000007067 DNA methylation Effects 0.000 description 1
241001502411 Damaliscus pygargus phillipsi Species 0.000 description 1
102000000541 Defensins Human genes 0.000 description 1
108010002069 Defensins Proteins 0.000 description 1
241000710829 Dengue virus group Species 0.000 description 1
241000238710 Dermatophagoides Species 0.000 description 1
241000238713 Dermatophagoides farinae Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241000243988 Dirofilaria immitis Species 0.000 description 1
201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
241001115402 Ebolavirus Species 0.000 description 1
241001466953 Echovirus Species 0.000 description 1
208000006586 Ectromelia Diseases 0.000 description 1
241000223931 Eimeria acervulina Species 0.000 description 1
241000289819 Eimeria adenoeides Species 0.000 description 1
241000499566 Eimeria brunetti Species 0.000 description 1
241001278028 Eimeria meleagrimitis Species 0.000 description 1
241000499563 Eimeria necatrix Species 0.000 description 1
241000886136 Eimeria scabra Species 0.000 description 1
241000304695 Eimeria sp. Species 0.000 description 1
241001485873 Eimeria stiedai Species 0.000 description 1
206010014418 Electrolyte imbalance Diseases 0.000 description 1
241000283090 Elephantidae Species 0.000 description 1
241000508725 Elymus repens Species 0.000 description 1
206010014584 Encephalitis california Diseases 0.000 description 1
241000710188 Encephalomyocarditis virus Species 0.000 description 1
206010014733 Endometrial cancer Diseases 0.000 description 1
206010014759 Endometrial neoplasm Diseases 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
208000037487 Endotoxemia Diseases 0.000 description 1
241000194032 Enterococcus faecalis Species 0.000 description 1
241001495410 Enterococcus sp. Species 0.000 description 1
241001442406 Enterocytozoon bieneusi Species 0.000 description 1
241000988559 Enterovirus A Species 0.000 description 1
241000709691 Enterovirus E Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000701081 Equid alphaherpesvirus 1 Species 0.000 description 1
241001598169 Equid alphaherpesvirus 3 Species 0.000 description 1
241000725578 Equid gammaherpesvirus 2 Species 0.000 description 1
208000000832 Equine Encephalomyelitis Diseases 0.000 description 1
240000007165 Eragrostis tenella Species 0.000 description 1
241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
208000000461 Esophageal Neoplasms Diseases 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
208000006168 Ewing Sarcoma Diseases 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
239000001576 FEMA 2977 Substances 0.000 description 1
241000204939 Fasciola gigantica Species 0.000 description 1
241000882763 Fascioloides magna Species 0.000 description 1
241000725579 Feline coronavirus Species 0.000 description 1
241000714165 Feline leukemia virus Species 0.000 description 1
241000701915 Feline panleukopenia virus Species 0.000 description 1
241001280522 Feline picornavirus Species 0.000 description 1
241000234642 Festuca Species 0.000 description 1
241000234645 Festuca pratensis Species 0.000 description 1
206010053717 Fibrous histiocytoma Diseases 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
241000711950 Filoviridae Species 0.000 description 1
241000710781 Flaviviridae Species 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
208000004262 Food Hypersensitivity Diseases 0.000 description 1
208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
208000000666 Fowlpox Diseases 0.000 description 1
241000605986 Fusobacterium nucleatum Species 0.000 description 1
241000701063 Gallid alphaherpesvirus 1 Species 0.000 description 1
241001660203 Gasterophilus Species 0.000 description 1
206010061968 Gastric neoplasm Diseases 0.000 description 1
208000005577 Gastroenteritis Diseases 0.000 description 1
241000283899 Gazella Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
208000034951 Genetic Translocation Diseases 0.000 description 1
241000250507 Gigaspora candida Species 0.000 description 1
208000032612 Glial tumor Diseases 0.000 description 1
206010018338 Glioma Diseases 0.000 description 1
229930186217 Glycolipid Natural products 0.000 description 1
241001506229 Goose reovirus Species 0.000 description 1
241000057766 Gymnostoma chamaecyparis Species 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
241000606790 Haemophilus Species 0.000 description 1
206010061192 Haemorrhagic fever Diseases 0.000 description 1
FOHHNHSLJDZUGQ-VWLOTQADSA-N Halofantrine Chemical compound FC(F)(F)C1=CC=C2C([C@@H](O)CCN(CCCC)CCCC)=CC3=C(Cl)C=C(Cl)C=C3C2=C1 FOHHNHSLJDZUGQ-VWLOTQADSA-N 0.000 description 1
241000406101 Hammondia Species 0.000 description 1
241000406097 Hammondia hammondi Species 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
241000150562 Hantaan orthohantavirus Species 0.000 description 1
241000713858 Harvey murine sarcoma virus Species 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
241000590002 Helicobacter pylori Species 0.000 description 1
208000002125 Hemangioendothelioma Diseases 0.000 description 1
208000006050 Hemangiopericytoma Diseases 0.000 description 1
208000001258 Hemangiosarcoma Diseases 0.000 description 1
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
241001494172 Henneguya Species 0.000 description 1
241000700739 Hepadnaviridae Species 0.000 description 1
206010019695 Hepatic neoplasm Diseases 0.000 description 1
208000005331 Hepatitis D Diseases 0.000 description 1
241001278020 Hepatozoon Species 0.000 description 1
241000149124 Hepatozoon canis Species 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
241000701020 Herpesvirus sylvilagus Species 0.000 description 1
241000226709 Hesperocyparis arizonica Species 0.000 description 1
241001290232 Hesperocyparis macrocarpa Species 0.000 description 1
240000007860 Heteropogon contortus Species 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241000948220 Histomonas meleagridis Species 0.000 description 1
241000228404 Histoplasma capsulatum Species 0.000 description 1
241000744855 Holcus Species 0.000 description 1
240000003857 Holcus lanatus Species 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
101000932480 Homo sapiens Fms-related tyrosine kinase 3 ligand Proteins 0.000 description 1
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
244000309469 Human enteric coronavirus Species 0.000 description 1
241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
241000829111 Human polyomavirus 1 Species 0.000 description 1
241000430519 Human rhinovirus sp. Species 0.000 description 1
241000617996 Human rotavirus Species 0.000 description 1
206010020843 Hyperthermia Diseases 0.000 description 1
206010020983 Hypogammaglobulinaemia Diseases 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
208000001953 Hypotension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
208000004467 Infectious Canine Hepatitis Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
208000006877 Insect Bites and Stings Diseases 0.000 description 1
102100037850 Interferon gamma Human genes 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108090000176 Interleukin-13 Proteins 0.000 description 1
108090000171 Interleukin-18 Proteins 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
208000009164 Islet Cell Adenoma Diseases 0.000 description 1
241001507061 Isopora Species 0.000 description 1
241000701460 JC polyomavirus Species 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
241000721668 Juniperus ashei Species 0.000 description 1
241000592238 Juniperus communis Species 0.000 description 1
241000701646 Kappapapillomavirus 2 Species 0.000 description 1
208000008839 Kidney Neoplasms Diseases 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
BFVQTKQTUCQRPI-YYEZTRBPSA-N LPS with O-antigen Chemical compound O([C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]5[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O5)O)O4)O)[C@@H](O)[C@@H](CO)O3)NC(C)=O)[C@@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)NC(C)=O)O2)NC(C)=O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)OC([C@@H]1O)O[C@H]1[C@H](O)[C@@H]([C@@H](O)COC2[C@H]([C@@H](O)[C@H](OP(O)(O)=O)[C@@H]([C@@H](O)CO)O2)O)OC([C@H]1O)O[C@H]1[C@H](OP(O)(=O)OP(O)(=O)OCCN)[C@@H]([C@@H](O)CO)OC([C@H]1O)O[C@H]1[C@H](O[C@]2(O[C@@H]([C@@H](O)[C@H](O[C@]3(O[C@@H]([C@@H](O)[C@H](OP(O)(=O)OCCN)C3)[C@@H](O)CO)C(O)=O)C2)[C@@H](O)CO)C(O)=O)C[C@](O[C@@H]1[C@@H](O)CO)(OC[C@H]1O[C@@H](OC[C@@H]2[C@H]([C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O2)O)[C@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@H]([C@@H]1OP(O)(O)=O)OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O BFVQTKQTUCQRPI-YYEZTRBPSA-N 0.000 description 1
201000009908 La Crosse encephalitis Diseases 0.000 description 1
241000282838 Lama Species 0.000 description 1
241000712902 Lassa mammarenavirus Species 0.000 description 1
241000589248 Legionella Species 0.000 description 1
208000007764 Legionnaires' Disease Diseases 0.000 description 1
241000222732 Leishmania major Species 0.000 description 1
208000004554 Leishmaniasis Diseases 0.000 description 1
241000700563 Leporipoxvirus Species 0.000 description 1
241000589902 Leptospira Species 0.000 description 1
206010024264 Lethargy Diseases 0.000 description 1
241001470497 Leucocytozoon Species 0.000 description 1
241000369001 Leucocytozoon danilewskyi Species 0.000 description 1
206010024503 Limb reduction defect Diseases 0.000 description 1
241000186779 Listeria monocytogenes Species 0.000 description 1
241000209082 Lolium Species 0.000 description 1
244000100545 Lolium multiflorum Species 0.000 description 1
240000004296 Lolium perenne Species 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
241000711828 Lyssavirus Species 0.000 description 1
241000282553 Macaca Species 0.000 description 1
241001115401 Marburgvirus Species 0.000 description 1
208000006758 Marek Disease Diseases 0.000 description 1
241000701244 Mastadenovirus Species 0.000 description 1
JCYZMTMYPZHVBF-UHFFFAOYSA-N Melarsoprol Chemical compound NC1=NC(N)=NC(NC=2C=CC(=CC=2)[As]2SC(CO)CS2)=N1 JCYZMTMYPZHVBF-UHFFFAOYSA-N 0.000 description 1
241000710185 Mengo virus Species 0.000 description 1
206010027202 Meningitis bacterial Diseases 0.000 description 1
208000037093 Menstruation Disturbances Diseases 0.000 description 1
206010027339 Menstruation irregular Diseases 0.000 description 1
241000002163 Mesapamea fractilinea Species 0.000 description 1
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical class COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
102000016397 Methyltransferase Human genes 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
229930191564 Monensin Natural products 0.000 description 1
GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
241000713333 Mouse mammary tumor virus Species 0.000 description 1
208000003445 Mouth Neoplasms Diseases 0.000 description 1
206010054877 Mucosal discolouration Diseases 0.000 description 1
241000711386 Mumps virus Species 0.000 description 1
241000711466 Murine hepatitis virus Species 0.000 description 1
241000711941 Murine orthopneumovirus Species 0.000 description 1
241001135960 Murine rotavirus Species 0.000 description 1
101100180428 Mus musculus Klk1b1 gene Proteins 0.000 description 1
241000282341 Mustela putorius furo Species 0.000 description 1
241000186367 Mycobacterium avium Species 0.000 description 1
241000187484 Mycobacterium gordonae Species 0.000 description 1
241000186364 Mycobacterium intracellulare Species 0.000 description 1
241000186363 Mycobacterium kansasii Species 0.000 description 1
241000224436 Naegleria Species 0.000 description 1
241000224438 Naegleria fowleri Species 0.000 description 1
208000006007 Nairobi Sheep Disease Diseases 0.000 description 1
241001457453 Nairobi sheep disease virus Species 0.000 description 1
241000588652 Neisseria gonorrhoeae Species 0.000 description 1
241000588650 Neisseria meningitidis Species 0.000 description 1
208000006816 Neonatal Sepsis Diseases 0.000 description 1
241001147660 Neospora Species 0.000 description 1
241001147662 Neospora caninum Species 0.000 description 1
208000005890 Neuroma Diseases 0.000 description 1
208000010359 Newcastle Disease Diseases 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
ARFHIAQFJWUCFH-IZZDOVSWSA-N Nifurtimox Chemical compound CC1CS(=O)(=O)CCN1\N=C\C1=CC=C([N+]([O-])=O)O1 ARFHIAQFJWUCFH-IZZDOVSWSA-N 0.000 description 1
241000714209 Norwalk virus Species 0.000 description 1
QWZRZYWLWTWVLF-UHFFFAOYSA-N O.OP(O)=O Chemical compound O.OP(O)=O QWZRZYWLWTWVLF-UHFFFAOYSA-N 0.000 description 1
206010030155 Oesophageal carcinoma Diseases 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
241000243985 Onchocerca volvulus Species 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
241000118010 Oodinium Species 0.000 description 1
241000702259 Orbivirus Species 0.000 description 1
241000933117 Oreotragus oreotragus Species 0.000 description 1
241000700629 Orthopoxvirus Species 0.000 description 1
241000702244 Orthoreovirus Species 0.000 description 1
241000243795 Ostertagia Species 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
108091081548 Palindromic sequence Proteins 0.000 description 1
241000282579 Pan Species 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
241000282373 Panthera pardus Species 0.000 description 1
241000282376 Panthera tigris Species 0.000 description 1
241000282520 Papio Species 0.000 description 1
241001648380 Parahaemoproteus Species 0.000 description 1
241000700639 Parapoxvirus Species 0.000 description 1
241000486442 Parastichtis suspecta Species 0.000 description 1
206010033976 Paravaccinia Diseases 0.000 description 1
241001465379 Parietaria judaica Species 0.000 description 1
241000721464 Parietaria officinalis Species 0.000 description 1
UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
241000701945 Parvoviridae Species 0.000 description 1
241000606860 Pasteurella Species 0.000 description 1
241000238661 Periplaneta Species 0.000 description 1
241000745991 Phalaris Species 0.000 description 1
244000081757 Phalaris arundinacea Species 0.000 description 1
241000746983 Phleum pratense Species 0.000 description 1
241001127637 Plantago Species 0.000 description 1
244000239204 Plantago lanceolata Species 0.000 description 1
235000010503 Plantago lanceolata Nutrition 0.000 description 1
241000224017 Plasmodium berghei Species 0.000 description 1
241001672077 Plasmodium relictum Species 0.000 description 1
206010035603 Pleural mesothelioma Diseases 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
241000209048 Poa Species 0.000 description 1
241000136254 Poa compressa Species 0.000 description 1
241000209049 Poa pratensis Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920002873 Polyethylenimine Polymers 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
241000282405 Pongo abelii Species 0.000 description 1
208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
208000024777 Prion disease Diseases 0.000 description 1
241000283080 Proboscidea <mammal> Species 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
208000001671 Pulmonary Adenomatosis Diseases 0.000 description 1
206010037423 Pulmonary oedema Diseases 0.000 description 1
241000282374 Puma concolor Species 0.000 description 1
102000013009 Pyruvate Kinase Human genes 0.000 description 1
108020005115 Pyruvate Kinase Proteins 0.000 description 1
241000219492 Quercus Species 0.000 description 1
244000274906 Quercus alba Species 0.000 description 1
235000009137 Quercus alba Nutrition 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
101100453992 Rattus norvegicus Ngfg gene Proteins 0.000 description 1
208000015634 Rectal Neoplasms Diseases 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
206010038389 Renal cancer Diseases 0.000 description 1
241000702263 Reovirus sp. Species 0.000 description 1
206010038997 Retroviral infections Diseases 0.000 description 1
241000712907 Retroviridae Species 0.000 description 1
206010039085 Rhinitis allergic Diseases 0.000 description 1
206010051497 Rhinotracheitis Diseases 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
241000606701 Rickettsia Species 0.000 description 1
244000004774 Sabina virginiana Species 0.000 description 1
235000008691 Sabina virginiana Nutrition 0.000 description 1
241000282695 Saimiri Species 0.000 description 1
241000242680 Schistosoma mansoni Species 0.000 description 1
241000209056 Secale Species 0.000 description 1
244000082988 Secale cereale Species 0.000 description 1
235000007238 Secale cereale Nutrition 0.000 description 1
201000010208 Seminoma Diseases 0.000 description 1
241000710961 Semliki Forest virus Species 0.000 description 1
201000001880 Sexual dysfunction Diseases 0.000 description 1
241000702677 Simian rotavirus Species 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
235000011684 Sorghum saccharatum Nutrition 0.000 description 1
239000004187 Spiramycin Substances 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
241001478880 Streptobacillus moniliformis Species 0.000 description 1
241000193985 Streptococcus agalactiae Species 0.000 description 1
241000194049 Streptococcus equinus Species 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
241000193996 Streptococcus pyogenes Species 0.000 description 1
241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
241001415849 Strigiformes Species 0.000 description 1
241000731779 Strongyloides westeri Species 0.000 description 1
241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
241000700568 Suipoxvirus Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
206010042566 Superinfection Diseases 0.000 description 1
108700025695 Suppressor Genes Proteins 0.000 description 1
208000033809 Suppuration Diseases 0.000 description 1
230000005867 T cell response Effects 0.000 description 1
108700026226 TATA Box Proteins 0.000 description 1
241000712908 Tacaribe mammarenavirus Species 0.000 description 1
206010057644 Testis cancer Diseases 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
210000000447 Th1 cell Anatomy 0.000 description 1
210000004241 Th2 cell Anatomy 0.000 description 1
241000223776 Theileria equi Species 0.000 description 1
241000223779 Theileria parva Species 0.000 description 1
208000001117 Theileriasis Diseases 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
208000024770 Thyroid neoplasm Diseases 0.000 description 1
HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 1
241000283907 Tragelaphus oryx Species 0.000 description 1
241000589886 Treponema Species 0.000 description 1
241000589904 Treponema pallidum subsp. pertenue Species 0.000 description 1
241001500087 Trichodina Species 0.000 description 1
241000224526 Trichomonas Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
241000209140 Triticum Species 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
241000224528 Tritrichomonas Species 0.000 description 1
241001058196 Tritrichomonas foetus Species 0.000 description 1
241000223105 Trypanosoma brucei Species 0.000 description 1
241000223091 Trypanosoma lewisi Species 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
241000282458 Ursus sp. Species 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
241001494970 Vesicular exanthema of swine virus Species 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
206010047400 Vibrio infections Diseases 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
206010051511 Viral diarrhoea Diseases 0.000 description 1
241000713325 Visna/maedi virus Species 0.000 description 1
208000010399 Wasting Syndrome Diseases 0.000 description 1
241000120645 Yellow fever virus group Species 0.000 description 1
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
206010000269 abscess Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000007950 acidosis Effects 0.000 description 1
208000026545 acidosis disease Diseases 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
210000005006 adaptive immune system Anatomy 0.000 description 1
208000009956 adenocarcinoma Diseases 0.000 description 1
201000008395 adenosquamous carcinoma Diseases 0.000 description 1
108700010877 adenoviridae proteins Proteins 0.000 description 1
201000005179 adrenal carcinoma Diseases 0.000 description 1
210000004712 air sac Anatomy 0.000 description 1
229920013820 alkyl cellulose Polymers 0.000 description 1
125000005600 alkyl phosphonate group Chemical group 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
201000010105 allergic rhinitis Diseases 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
230000001668 ameliorated effect Effects 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229960003942 amphotericin b Drugs 0.000 description 1
229960003683 amprolium Drugs 0.000 description 1
239000003708 ampul Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229940124339 anthelmintic agent Drugs 0.000 description 1
239000000921 anthelmintic agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000078 anti-malarial effect Effects 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
210000000436 anus Anatomy 0.000 description 1
238000002617 apheresis Methods 0.000 description 1
230000004596 appetite loss Effects 0.000 description 1
239000000823 artificial membrane Substances 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000010425 asbestos Substances 0.000 description 1
201000009361 ascariasis Diseases 0.000 description 1
244000309743 astrovirus Species 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
229940090047 auto-injector Drugs 0.000 description 1
201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
241000701792 avian adenovirus Species 0.000 description 1
201000009904 bacterial meningitis Diseases 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
150000001556 benzimidazoles Chemical class 0.000 description 1
229960004001 benznidazole Drugs 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
201000009036 biliary tract cancer Diseases 0.000 description 1
208000020790 biliary tract neoplasm Diseases 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
229960002326 bithionol Drugs 0.000 description 1
208000034158 bleeding Diseases 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000007885 bronchoconstriction Effects 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
210000001669 bursa of fabricius Anatomy 0.000 description 1
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
229960003475 cambendazole Drugs 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
231100000315 carcinogenic Toxicity 0.000 description 1
208000002458 carcinoid tumor Diseases 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
229920006217 cellulose acetate butyrate Polymers 0.000 description 1
229940081734 cellulose acetate phthalate Drugs 0.000 description 1
229920003086 cellulose ether Polymers 0.000 description 1
229920006218 cellulose propionate Polymers 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
210000000991 chicken egg Anatomy 0.000 description 1
229940038705 chlamydia trachomatis Drugs 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
229960003677 chloroquine Drugs 0.000 description 1
WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
229960002328 chloroquine phosphate Drugs 0.000 description 1
150000001840 cholesterol esters Chemical class 0.000 description 1
LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
229960002227 clindamycin Drugs 0.000 description 1
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
229960000275 clorsulon Drugs 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
238000007398 colorimetric assay Methods 0.000 description 1
230000002301 combined effect Effects 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
201000005332 contagious pustular dermatitis Diseases 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
239000012050 conventional carrier Substances 0.000 description 1
230000036461 convulsion Effects 0.000 description 1
201000002951 cornea squamous cell carcinoma Diseases 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000139 costimulatory effect Effects 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
201000003740 cowpox Diseases 0.000 description 1
239000006071 cream Substances 0.000 description 1
239000003431 cross linking reagent Substances 0.000 description 1
239000000287 crude extract Substances 0.000 description 1
238000000315 cryotherapy Methods 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
JHAYEQICABJSTP-UHFFFAOYSA-N decoquinate Chemical compound N1C=C(C(=O)OCC)C(=O)C2=C1C=C(OCC)C(OCCCCCCCCCC)=C2 JHAYEQICABJSTP-UHFFFAOYSA-N 0.000 description 1
229960001878 decoquinate Drugs 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
XXLZPUYGHQWHRN-RPBOFIJWSA-N dehydroemetine Chemical compound COC1=C(OC)C=C2[C@@H]3CC(C[C@@H]4C5=CC(OC)=C(OC)C=C5CCN4)=C(CC)CN3CCC2=C1 XXLZPUYGHQWHRN-RPBOFIJWSA-N 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000009795 derivation Methods 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 description 1
229960003974 diethylcarbamazine Drugs 0.000 description 1
230000029087 digestion Effects 0.000 description 1
229960003061 dihydroemetine Drugs 0.000 description 1
229960000691 diiodohydroxyquinoline Drugs 0.000 description 1
BDYYDXJSHYEDGB-UHFFFAOYSA-N diloxanide furoate Chemical compound C1=CC(N(C(=O)C(Cl)Cl)C)=CC=C1OC(=O)C1=CC=CO1 BDYYDXJSHYEDGB-UHFFFAOYSA-N 0.000 description 1
229960003497 diloxanide furoate Drugs 0.000 description 1
PSLWZOIUBRXAQW-UHFFFAOYSA-M dimethyl(dioctadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC PSLWZOIUBRXAQW-UHFFFAOYSA-M 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
AXRWJSAOLNNBNI-UHFFFAOYSA-L disodium;2-[(4-carbamoylphenyl)-(carboxylatomethylsulfanyl)arsanyl]sulfanylacetate Chemical compound [Na+].[Na+].NC(=O)C1=CC=C([As](SCC([O-])=O)SCC([O-])=O)C=C1 AXRWJSAOLNNBNI-UHFFFAOYSA-L 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002612 dispersion medium Substances 0.000 description 1
GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
238000012137 double-staining Methods 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
229960003722 doxycycline Drugs 0.000 description 1
239000006196 drop Substances 0.000 description 1
229940000406 drug candidate Drugs 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
239000000428 dust Substances 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
239000012636 effector Substances 0.000 description 1
229960002759 eflornithine Drugs 0.000 description 1
VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 1
238000001378 electrochemiluminescence detection Methods 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000013020 embryo development Effects 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
201000002491 encephalomyelitis Diseases 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000007071 enzymatic hydrolysis Effects 0.000 description 1
238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
230000013764 eosinophil chemotaxis Effects 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
201000004101 esophageal cancer Diseases 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical class CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229940093476 ethylene glycol Drugs 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
239000003925 fat Substances 0.000 description 1
206010016256 fatigue Diseases 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
208000005098 feline infectious peritonitis Diseases 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
201000003444 follicular lymphoma Diseases 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000020932 food allergy Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
201000006585 gastric adenocarcinoma Diseases 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
208000017215 gastric mucosa-associated lymphoid tissue lymphoma Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
229940085435 giardia lamblia Drugs 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 description 1
208000027096 gram-negative bacterial infections Diseases 0.000 description 1
208000017750 granulocytic sarcoma Diseases 0.000 description 1
210000004524 haematopoietic cell Anatomy 0.000 description 1
229960003242 halofantrine Drugs 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
230000012447 hatching Effects 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
210000002443 helper t lymphocyte Anatomy 0.000 description 1
201000001505 hemoglobinuria Diseases 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
208000029570 hepatitis D virus infection Diseases 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
244000144980 herd Species 0.000 description 1
IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
201000000284 histiocytoma Diseases 0.000 description 1
230000002962 histologic effect Effects 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
PJBQYZZKGNOKNJ-UHFFFAOYSA-M hydron;5-[(2-methylpyridin-1-ium-1-yl)methyl]-2-propylpyrimidin-4-amine;dichloride Chemical compound Cl.[Cl-].NC1=NC(CCC)=NC=C1C[N+]1=CC=CC=C1C PJBQYZZKGNOKNJ-UHFFFAOYSA-M 0.000 description 1
229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
230000033444 hydroxylation Effects 0.000 description 1
238000005805 hydroxylation reaction Methods 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000036031 hyperthermia Effects 0.000 description 1
238000009217 hyperthermia therapy Methods 0.000 description 1
230000002218 hypoglycaemic effect Effects 0.000 description 1
230000036543 hypotension Effects 0.000 description 1
230000005965 immune activity Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
230000000899 immune system response Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
230000006054 immunological memory Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000001024 immunotherapeutic effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229940102213 injectable suspension Drugs 0.000 description 1
239000002919 insect venom Substances 0.000 description 1
239000002917 insecticide Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
206010022498 insulinoma Diseases 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
230000002601 intratumoral effect Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
UXZFQZANDVDGMM-UHFFFAOYSA-N iodoquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(I)C2=C1 UXZFQZANDVDGMM-UHFFFAOYSA-N 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
206010023332 keratitis Diseases 0.000 description 1
201000010666 keratoconjunctivitis Diseases 0.000 description 1
208000022013 kidney Wilms tumor Diseases 0.000 description 1
201000010982 kidney cancer Diseases 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
206010023497 kuru Diseases 0.000 description 1
238000009533 lab test Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
238000002647 laser therapy Methods 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
229940087875 leukine Drugs 0.000 description 1
206010024378 leukocytosis Diseases 0.000 description 1
201000002364 leukopenia Diseases 0.000 description 1
231100001022 leukopenia Toxicity 0.000 description 1
230000000610 leukopenic effect Effects 0.000 description 1
239000003446 ligand Substances 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
239000010807 litter Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000012153 long-term therapy Methods 0.000 description 1
208000019017 loss of appetite Diseases 0.000 description 1
235000021266 loss of appetite Nutrition 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
201000006385 lung benign neoplasm Diseases 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
201000011649 lymphoblastic lymphoma Diseases 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000005541 medical transmission Effects 0.000 description 1
229960001962 mefloquine Drugs 0.000 description 1
XOGYVDXPYVPAAQ-SESJOKTNSA-M meglumine antimoniate Chemical compound O[Sb](=O)=O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO XOGYVDXPYVPAAQ-SESJOKTNSA-M 0.000 description 1
229940005559 meglumine antimoniate Drugs 0.000 description 1
MGEOLZFMLHYCFZ-UHFFFAOYSA-N melarsomine Chemical compound C1=CC([As](SCCN)SCCN)=CC=C1NC1=NC(N)=NC(N)=N1 MGEOLZFMLHYCFZ-UHFFFAOYSA-N 0.000 description 1
229960002234 melarsomine Drugs 0.000 description 1
229960001728 melarsoprol Drugs 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
230000015654 memory Effects 0.000 description 1
231100000544 menstrual irregularity Toxicity 0.000 description 1
229960000901 mepacrine Drugs 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
125000005395 methacrylic acid group Chemical group 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
244000000010 microbial pathogen Species 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 description 1
229940099245 milbemycin oxime Drugs 0.000 description 1
ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229960005358 monensin Drugs 0.000 description 1
GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
208000005871 monkeypox Diseases 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
229960004816 moxidectin Drugs 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
206010028417 myasthenia gravis Diseases 0.000 description 1
208000009091 myxoma Diseases 0.000 description 1
ZLDPNFYTUDQDMJ-UHFFFAOYSA-N n-octadecyloctadecan-1-amine;hydrobromide Chemical compound Br.CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCC ZLDPNFYTUDQDMJ-UHFFFAOYSA-N 0.000 description 1
210000004296 naive t lymphocyte Anatomy 0.000 description 1
239000002088 nanocapsule Substances 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
208000025189 neoplasm of testis Diseases 0.000 description 1
210000003757 neuroblast Anatomy 0.000 description 1
208000029974 neurofibrosarcoma Diseases 0.000 description 1
230000002981 neuropathic effect Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
239000002547 new drug Substances 0.000 description 1
229960001920 niclosamide Drugs 0.000 description 1
RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 1
229960002644 nifurtimox Drugs 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
210000001331 nose Anatomy 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
210000003250 oocyst Anatomy 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
208000008798 osteoma Diseases 0.000 description 1
201000005193 ostertagiasis Diseases 0.000 description 1
210000004681 ovum Anatomy 0.000 description 1
XCGYUJZMCCFSRP-UHFFFAOYSA-N oxamniquine Chemical compound OCC1=C([N+]([O-])=O)C=C2NC(CNC(C)C)CCC2=C1 XCGYUJZMCCFSRP-UHFFFAOYSA-N 0.000 description 1
229960000462 oxamniquine Drugs 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
208000012307 pale mucous membrane Diseases 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
208000021255 pancreatic insulinoma Diseases 0.000 description 1
208000029211 papillomatosis Diseases 0.000 description 1
230000024241 parasitism Effects 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
229960001914 paromomycin Drugs 0.000 description 1
238000009304 pastoral farming Methods 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
102000007863 pattern recognition receptors Human genes 0.000 description 1
108010089193 pattern recognition receptors Proteins 0.000 description 1
239000008188 pellet Substances 0.000 description 1
YBVNFKZSMZGRAD-UHFFFAOYSA-N pentamidine isethionate Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 YBVNFKZSMZGRAD-UHFFFAOYSA-N 0.000 description 1
229960001624 pentamidine isethionate Drugs 0.000 description 1
210000004976 peripheral blood cell Anatomy 0.000 description 1
239000012466 permeate Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000008288 physiological mechanism Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
229920000233 poly(alkylene oxides) Polymers 0.000 description 1
229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229920000196 poly(lauryl methacrylate) Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
229920001281 polyalkylene Polymers 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229920001610 polycaprolactone Polymers 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920006149 polyester-amide block copolymer Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920000129 polyhexylmethacrylate Polymers 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
239000011118 polyvinyl acetate Substances 0.000 description 1
235000019422 polyvinyl alcohol Nutrition 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
229920001289 polyvinyl ether Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
229960005462 primaquine phosphate Drugs 0.000 description 1
208000016800 primary central nervous system lymphoma Diseases 0.000 description 1
230000001566 pro-viral effect Effects 0.000 description 1
229960005385 proguanil Drugs 0.000 description 1
SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
QZWHWHNCPFEXLL-UHFFFAOYSA-N propan-2-yl n-[2-(1,3-thiazol-4-yl)-3h-benzimidazol-5-yl]carbamate Chemical compound N1C2=CC(NC(=O)OC(C)C)=CC=C2N=C1C1=CSC=N1 QZWHWHNCPFEXLL-UHFFFAOYSA-N 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
208000023958 prostate neoplasm Diseases 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
229940070376 protein Drugs 0.000 description 1
239000002423 protozoacide Substances 0.000 description 1
208000005333 pulmonary edema Diseases 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
XHKUDCCTVQUHJQ-LCYSNFERSA-N quinidine D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 XHKUDCCTVQUHJQ-LCYSNFERSA-N 0.000 description 1
229960002454 quinidine gluconate Drugs 0.000 description 1
229960003110 quinine sulfate Drugs 0.000 description 1
MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
108700042226 ras Genes Proteins 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
206010038038 rectal cancer Diseases 0.000 description 1
201000001275 rectum cancer Diseases 0.000 description 1
235000018770 reduced food intake Nutrition 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
201000009410 rhabdomyosarcoma Diseases 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
206010039083 rhinitis Diseases 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
229910052895 riebeckite Inorganic materials 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
108010038379 sargramostim Proteins 0.000 description 1
210000001563 schizont Anatomy 0.000 description 1
238000000926 separation method Methods 0.000 description 1
208000026775 severe diarrhea Diseases 0.000 description 1
231100000872 sexual dysfunction Toxicity 0.000 description 1
230000035939 shock Effects 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
201000010088 skin benign neoplasm Diseases 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229940083542 sodium Drugs 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
UEYIAABRKWHXJV-UHFFFAOYSA-M sodium;2-(4-arsonoanilino)ethanimidate Chemical compound [Na+].NC(=O)CNC1=CC=C([As](O)([O-])=O)C=C1 UEYIAABRKWHXJV-UHFFFAOYSA-M 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
235000019372 spiramycin Nutrition 0.000 description 1
229960001294 spiramycin Drugs 0.000 description 1
229930191512 spiramycin Natural products 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
210000004215 spore Anatomy 0.000 description 1
239000007921 spray Substances 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
235000020354 squash Nutrition 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000012289 standard assay Methods 0.000 description 1
229940031000 streptococcus pneumoniae Drugs 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
230000002311 subsequent effect Effects 0.000 description 1
ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 description 1
229960000973 sulfadimethoxine Drugs 0.000 description 1
229960002135 sulfadimidine Drugs 0.000 description 1
229960004673 sulfadoxine Drugs 0.000 description 1
ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 description 1
229960005404 sulfamethoxazole Drugs 0.000 description 1
229960003097 sulfaquinoxaline Drugs 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
125000004434 sulfur atom Chemical group 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
229960005314 suramin Drugs 0.000 description 1
FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
208000008732 thymoma Diseases 0.000 description 1
201000002510 thyroid cancer Diseases 0.000 description 1
229960005053 tinidazole Drugs 0.000 description 1
239000003104 tissue culture media Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
229940118701 toxoplasma gondii Drugs 0.000 description 1
230000032258 transport Effects 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
239000013638 trimer Substances 0.000 description 1
229950000574 tryparsamide Drugs 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
230000037455 tumor specific immune response Effects 0.000 description 1
230000029069 type 2 immune response Effects 0.000 description 1
230000005951 type IV hypersensitivity Effects 0.000 description 1
208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
241000990167 unclassified Simian adenoviruses Species 0.000 description 1
241000724775 unclassified viruses Species 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
229940005605 valeric acid Drugs 0.000 description 1
201000006266 variola major Diseases 0.000 description 1
201000000627 variola minor Diseases 0.000 description 1
208000014016 variola minor infection Diseases 0.000 description 1
231100000611 venom Toxicity 0.000 description 1
229920001567 vinyl ester resin Polymers 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1